NK:IO
London
About NK:IO
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Funding stage: Seed
- Last round: Seed (Jul 2023)
- Website: nk-io.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/nk-io-13509 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.